Eli Lilly's Weight-Loss Drug Zepbound and Diabetes Treatment Mounjaro Drive Record Earnings

The pharmaceutical giant surpasses market expectations with strong Q4 results, buoyed by soaring demand for its obesity and diabetes medications.